维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="SOLIT DB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sentitizing tumors to paclitaxel显示文摘	Solit DB She Y Lobe J	2005	clin cancer Res2005，11，：	1
2	In- hibition of heart shock protein in 90 function down-regulates Akt kinase and sensitizes tumors to taxol显示文摘	Solit DB Basso AD Olshen AB	2003	Cancer Res2003，62，9：	1
3	HsP90:a novel target for cancer therapy显示文摘	Solit DB Rosen N	2006	Curr Top Med Chem2006，6，11：	1
4	BRAF mutation predicts sensitivity to MEK inhibition 显示文摘	Solit DB Garraway LA Pratilas CA	2006	Nature2006，439，7074：	1
5	Akt forms an intracellular comJplex with heat shock Protein 90 (HSP90) and Cdc37 andis destabilized by Inhibitors of HSP90 funCtion 显示文摘	Basso AD Solit DB Chiosis G	2002	Biol Chem2002，277，39：	1
6	KRAS and BRAF:drug targets and predictive biomarkers显示文摘	Vakiani E Solit DB		0，，02：	1
7	Development and application oi Hsp90 inhibitors显示文摘	Solit DB Chiosis G	2008	Drug Discov Today2008，13，12：	1
8	Inhibition of heat shock protein 90 function downregulatesAkt kinase and sensitizes tumors to Taxol 显示文摘	Solit DB Basso AD Olshen AB	2003	Cancer Res2003，63，：	1
9	A phase Ⅰ trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors显示文摘	Fury MG Solit DB Su YB	2007	Cancer Chemother Pharmacol2007，59，：	1
10	KRAS and BRAF: drug targets and predictive biomarkers 显示文摘	Vakiani E Solit DB	2011	J Pathol2011，223，2：	1
11	Inhibition of heat shock protein 90 function down-regnlates Akt kinase and sensitizes tumors to Taxol显示文摘	Basso AD Olshen AB	2003	Cancer Res2003，63，9：	1
12	T he BAD protein integrates survival signaling by egfr/mapk and PI 3 K/akt kinase pathways in pten-deficient tumor ceils 显示文摘	She QB Solit DB Ye Q	2005	Cancer Cell2005，8，4：	1
13	Phase 1I trial of 17- allylamino-17-demethoxygeldanamycin in patients with me-tastatic melanoma 显示文摘	Solit DB Osman I Polsky D et ol	2008	Clin Cancer Res2008，14，24：	1
14	KRAS and BRAF:drug targets and predic- tive biomarkers 显示文摘	Vakiani E Solit DB	2011	J Pathol2011，223，2：	1
15	Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tu- mors to Taxol显示文摘	Solit DB Basso AD Olshen AB Scher HI Rosen N	2003	Cancer Res2003，，：	1
16	KRAS and BRAF: drug targets and predictive biomarkers显示文摘	Vakiani E Solit DB	2011	J Pathol2011，223，2：	1
17	17-Allylamino-17- demethoxy-geldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibitor growth of prostate cancer xcnografts显示文摘	Solit DB Zheng FF Drobnjak M	2002	Clin Cancer Res2002，8，：	1
18	Therapeutic strategies for inhibiting oncogenic BRAF signaling显示文摘	Halilovic E Solit DB	2008	Curr Opin Pharmacol2008，8，4：	1
19	BRAF mutation predicts sensitivity to MEK inhibition显示文摘	Solit DB Garraway LA Pratilas CA	2006	Nature2006，439，7074：	1
20	Targeting the mitogen-activated pro- tein kinase pathway: physiological feedback and drug response 显示文摘	PRATILAS CA SOLIT DB	2010	Clin Cancer Res2010，16，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示